Language:
Tateishi

Ryosuke Tateishi

Partner
Baker & McKenzie (Gaikokuho Joint Enterprise)

Biography

Ryosuke Tateishi is a partner of the Tokyo Corporate/M&A and Dispute Resolution groups. Prior to joining Baker McKenzie, Ryosuke worked for Sumitomo Corporation. He is a member of the Daini Tokyo Bar Association and has been a METI-registered management consultant since 2003.

Practice Focus

Ryosuke focuses his practice on general corporate law matters, and specializes in assisting domestic and overseas companies in health care-related industries — including the pharmaceutical, medical device and food industries — with compliance under the Pharmaceutical and Medical Devices Act, the Food Hygiene Act, the Food Labelling Act, the Anti-monopoly Act and the Act against Unjustifiable Premiums and Misleading Representations, among others. Ryosuke also provides anti-bribery policy compliance assistance.

Representative Legal Matters

  • Assisted a multinational pharmaceutical company in connection with supply of COVID19-related products to Japan.
  • Assisted a US biopharmaceutical company in collaboration project for development and commercialization of Alzheimer-related products.
  • Assisted a regenerative medical products manufacturer in establishing and implementing compliance program.
  • Provided legal and compliance support for companies developing robotic technologies in healthcare industry.
  • Provided legal and compliance support for technology companies and medical device companies in connection with development and supply of wearable devices and relevant healthcare software.
  • Assisted a US medical device manufacturer with dispute resolution, crisis management, internal investigation and compliance, including anti-bribery policy compliance.
  • Assisted a UK pharmaceutical company in establishing a compliance program concerning off-label information disclosure.
  • Assisted a US pharmaceutical company in establishing a compliance program concerning advertising, including disease awareness activities.
  • Assisted a US pharmaceutical company in conducting a "deep dive" compliance audit.
  • Provided legal advice and assisted a number of pharmaceutical companies and medical device companies in license agreements and collaboration transactions.

Professional Associations and Memberships

  • Daini Tokyo Bar Association 
  • New York State Bar Association
  • American Bar Association

Admissions

  • New York~United States (2015)
  • Japan (2008)

Education

  • University of California at Los Angeles (LL.M.) (2014)
  • Waseda University (J.D.) (2007)
  • The University of Tokyo (LL.B.) (1998)

Languages

  • English
  • Japanese
  • Author, "Legal considerations for commercializing digital health products," Presentation, Johokiko Co., Ltd., February 2022
  • Author, "Legal Mind November 2021," Japan Pharmaceutical Industry Legal Affairs Association Journal, November 2021
  • Author, "Legal considerations for commercializing digital health products," Japan Pharmaceutical Industry Legal Affairs Association monthly meeting, September 2021
  • Author, "Impact of "Guidelines about Sales Information Provision Activities," on pharmaceutical companies", PHARMSTAGE, Technical Information Institute, April 2020
  • Co-author "Explanation about Foreign Bribery Guidance," Monthly Audit, Japan Audit & Supervisory Board Members Association, No. 663, February 2017 
  • Co-author, "Trend enforcement by US, UK and China authority and necessary compliance procedure," Business Law Journal, LexisNexis, November 2015